M&T Bank’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Sell
763
-194
-20% -$89.5K ﹤0.01% 1312
2026
Q1
$459K Sell
957
-127
-12% -$65K ﹤0.01% 1169
2025
Q4
$609K Buy
1,084
+251
+30% +$142K ﹤0.01% 1030
2025
Q3
$428K Sell
833
-106
-11% -$46.3K ﹤0.01% 1048
2025
Q2
$295K Buy
939
+31
+3% +$9.31K ﹤0.01% 1277
2025
Q1
$277K Sell
908
-248
-21% -$83.4K ﹤0.01% 1291
2024
Q4
$384K Sell
1,156
-2,043
-64% -$693K ﹤0.01% 1272
2024
Q3
$1.07M Buy
3,199
+37
+1% +$14.1K ﹤0.01% 885
2024
Q2
$1.3M Buy
3,162
+295
+10% +$117K ﹤0.01% 788
2024
Q1
$1.16M Sell
2,867
-123
-4% -$43.2K ﹤0.01% 832
2023
Q4
$917K Buy
2,990
+1,685
+129% +$455K ﹤0.01% 897
2023
Q3
$316K Buy
1,305
+257
+25% +$65.7K ﹤0.01% 1253
2023
Q2
$252K Sell
1,048
-36
-3% -$7.48K ﹤0.01% 1376
2023
Q1
$204K Buy
1,084
+36
+3% +$7.45K ﹤0.01% 1472
2022
Q4
$223K Buy
+1,048
New +$209K ﹤0.01% 1427
2022
Q3
Sell
-3,514
Closed -$525K 1653
2022
Q2
$525K Buy
3,514
+2,264
+181% +$328K ﹤0.01% 989
2022
Q1
$204K Buy
1,250
+275
+28% +$45.3K ﹤0.01% 1380
2021
Q4
$212K Sell
975
-125
-11% -$26.2K ﹤0.01% 1431
2021
Q3
$208K Buy
+1,100
New +$201K ﹤0.01% 1427

Other funds holding MEDP

M&T Bank's MEDP Position: Q2 2026 in Review

M&T Bank reduced its Medpace (MEDP) stake by 20% in Q2 2026, selling an estimated $89.5K and leaving 763 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

M&T Bank first reported a position in MEDP in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.3M in Q2 2024. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • M&T Bank held 763 shares of Medpace worth $404K as of Q2 2026.
  • M&T Bank sold 194 Medpace shares in Q2 2026, an estimated $89.5K.
  • Medpace made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1312 holding.
  • M&T Bank first reported a position in Medpace in Q3 2021 and has held it in 19 quarters since.
  • M&T Bank's Medpace position peaked at $1.3M in Q2 2024.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.